Home/Filings/4/0000950170-24-028807
4//SEC Filing

Bensen Daniel 4

Accession 0000950170-24-028807

CIK 0001863127other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 5:38 PM ET

Size

6.3 KB

Accession

0000950170-24-028807

Insider Transaction Report

Form 4
Period: 2024-03-06
Bensen Daniel
Chief Discovery Officer
Transactions
  • Sale

    Common Stock

    2024-03-07$20.00/sh68$1,360431,883 total
  • Sale

    Common Stock

    2024-03-06$20.09/sh1,733$34,819431,951 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.
  • [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.39. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Documents

1 file

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001880946

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:38 PM ET
Size
6.3 KB